logo
Select company
Select metric
$ -0.05EBITDA per Share
VS
Market
33
Sector
72
Industry
89
History
78
$ 0.23Close
$ 0.19 - $ 0.44 52-Week Range
Ticker Information

Ticker

NWBO

Company Name

NORTHWEST BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

NORTHWEST BIOTHERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NWBO - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -72.28M$ -0.0511.44B
3/31/2025$ -74.92M$ -0.0611.36B
12/31/2024$ -73.97M$ -0.0611.24B
9/30/2024$ -65.99M$ -0.0511.26B
6/30/2024$ -65.64M$ -0.0511.21B
3/31/2024$ -62.69M$ -0.0511.19B
12/31/2023$ -55.63M$ -0.0511.12B
9/30/2023$ -65.06M$ -0.0611.13B
6/30/2023$ -79.61M$ -0.0711.11B
3/31/2023$ -94.54M$ -0.0911.07B
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NORTHWEST BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -0.31.
  • Over the past 5 years, NORTHWEST BIOTHERAPEUTICS INC's average EBITDAPS has been $ -0.13.
  • The median EBITDAPS for NORTHWEST BIOTHERAPEUTICS INC during this period was $ -0.06
  • NORTHWEST BIOTHERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ 0.21.
  • The lowest EBITDAPS recorded by NORTHWEST BIOTHERAPEUTICS INC in the same timeframe $ -0.72

NORTHWEST BIOTHERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
RNAC : CARTESIAN THERAPEUTICS INC $ -1.22INBX : INHIBRX BIOSCIENCES INC $ -9.91HUMA : HUMACYTE INC $ -0.26ABEO : ABEONA THERAPEUTICS INC $ 1.52MREO : MEREO BIOPHARMA GROUP PLC $ -0.31SEPN : SEPTERNA INC $ -1.91CRDF : CARDIFF ONCOLOGY INC $ -0.76CATX : PERSPECTIVE THERAPEUTICS INC $ -1.27BTAI : BIOXCEL THERAPEUTICS INC $ -4.41ADVM : ADVERUM BIOTECHNOLOGIES INC $ -7.63

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: EBITDA [ $ -235.19M ] / (Shares WA [ 747.75M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.31 ]

NWBO - EBITDA per Share, Last 5 years

$ -0.72

Minimum

Dec 31, 2020

$ 0.21

Maximum

Dec 31, 2021

$ -0.13

Average

$ -0.06

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26